Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D3TB
|
||||
Former ID |
DNC013495
|
||||
Drug Name |
N-ALLYLNORGALANTHAMINE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529384] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H23NO3
|
||||
Canonical SMILES |
COC1=C2C3=C(CN(CCC34C=CC(CC4O2)O)CC=C)C=C1
|
||||
InChI |
1S/C19H23NO3/c1-3-9-20-10-8-19-7-6-14(21)11-16(19)23-18-15(22-2)5-4-13(12-20)17(18)19/h3-7,14,16,21H,1,8-12H2,2H3/t14-,16-,19-/m0/s1
|
||||
InChIKey |
BQESVZIPHFRYNG-QOKNQOGYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [529384] | |
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.